Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment

Current antiplatelet drugs for the treatment of arterial thrombosis often coincide with increased bleeding risk. Several tyrosine kinase inhibitors (TKIs) for cancer treatment inhibit platelet function, with minor reported bleeding symptoms. The aim of this study was to compare the antiplatelet prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tullemans, Bibian M. E., Veninga, Alicia, Fernandez, Delia I., Aarts, Maureen J. B., Eble, Johannes A., van der Meijden, Paola E. J., Heemskerk, Johan W. M., Kuijpers, Marijke J. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540269/
https://www.ncbi.nlm.nih.gov/pubmed/34681859
http://dx.doi.org/10.3390/ijms222011199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540269/
https://www.ncbi.nlm.nih.gov/pubmed/34681859
http://dx.doi.org/10.3390/ijms222011199

Ejemplares similares